STOCK TITAN

Cronos Group (CRON) Stock News, Nov 2020-May 2021

CRON Nasdaq

Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.

Cronos Group Inc. reports developments for a global cannabis and cannabinoid company focused on consumer goods, cannabis research, technology and product development. Its brand portfolio includes Spinach®, PEACE NATURALS®, LIT® and Lord Jones®, with news often centered on product innovation across Canadian cannabis formats such as pre-rolls and vapes.

Recurring Cronos updates also cover operating and financial results, earnings conference calls, annual shareholder meetings, proxy and governance matters, capital-structure disclosures and public-company presentations. The company’s disclosures connect brand launches and R&D-driven product development with the financial and governance reporting of a Nasdaq- and TSX-listed cannabis issuer.

Rhea-AI Summary

Cronos Group recently announced its Q1 2021 results, reporting consolidated net revenue of $12.6 million, a 50% increase from Q1 2020, driven by growth in the Canadian and Israeli markets. Despite increased sales, the company experienced a gross loss of $2.96 million, improved from $6.48 million a year prior. The newly acquired processing license for cannabinoid biosynthesis is a significant achievement, supporting innovative product development. However, adjusted EBITDA loss slightly increased to $37.1 million, reflecting higher marketing and R&D costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
-
Rhea-AI Summary

Cronos Group Inc. (NASDAQ: CRON) will hold its 2021 Annual Meeting of Shareholders on June 25, 2021, at 11:00 a.m. EDT in a virtual format due to COVID-19 health concerns. Shareholders and proxyholders can participate online, ask questions, and vote. The proxy statement with meeting details is available on the Company’s website. A replay of the meeting will be accessible within 24 hours post-event. Cronos Group, a global cannabinoid company, focuses on advancing cannabis research and product development, aiming to enhance consumer experience through a diverse brand portfolio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.56%
Tags
none
-
Rhea-AI Summary

Cronos Group Inc. (NASDAQ: CRON) will host its 2021 First Quarter Earnings Conference Call on May 7, 2021, at 8:30 a.m. EDT. The call will allow management to discuss the company's financial results and address questions from investors. A live audio webcast will be available on the company's website, with an archived replay afterward. Cronos Group focuses on cannabinoid production and is building a diverse brand portfolio, including various wellness and hemp-derived CBD brands.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.49%
Tags
conferences earnings
Rhea-AI Summary

Cronos Group announces the launch of its first brand campaign for the Lord Jones™ brand, named “A Higher Order”, aimed at expanding its market presence in the U.S. This campaign includes out-of-home advertising and television spots featuring new creative assets, which showcase the brand's premium CBD products. The initiative reflects the brand's evolution and commitment to elevating consumer wellness experiences.

The campaign will be celebrated with a live-streamed “Sunday Bath Session” on May 2, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.8%
Tags
none
-
Rhea-AI Summary

Cronos Group (NASDAQ: CRON) has announced that its Happy Dance CBD skincare line is now available at over 550 Ulta Beauty locations and online. This marks the brand's first entry into physical retail, enhancing its visibility and accessibility. Happy Dance, co-founded by actress Kristen Bell, features vegan, cruelty-free products, with a portion of profits supporting a Black-owned reentry project. The partnership is highlighted by a dedicated display in Ulta stores, aiming to appeal to a wider audience and promote self-care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.19%
Tags
none
-
Rhea-AI Summary

Cronos Group announced its 2020 fourth quarter and full-year results, revealing a net revenue increase of 133% in Q4 2020 compared to Q4 2019, reaching $17.0 million. The company also saw significant growth in the U.S. and Israeli markets. However, a gross loss of $14.9 million was reported, despite a $5.2 million improvement from the previous year. The company holds approximately $1.3 billion in cash and short-term investments. Significant investments in brand expansion include the launch of Happy Dance™ products at ULTA Beauty™, enhancing its portfolio in the U.S. market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.15%
Tags
none
Rhea-AI Summary

Cronos Group Inc. (NASDAQ: CRON) will host its 2020 Fourth Quarter and Full-year Earnings Conference Call on February 26, 2021, at 8:30 a.m. EST. Senior management will discuss the Company’s financial results, followed by a Q&A session. Investors can tune in via a live audio webcast on the Company’s website. Participants can also listen by phone, with access numbers provided. The Company focuses on innovative cannabinoid products and aims to develop an iconic brand portfolio across five continents.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.99%
Tags
conferences earnings
-
Rhea-AI Summary

Cronos Group announced that its CEO, Kurt Schmidt, will present at the 24th Annual CIBC Western Institutional Investor Conference on January 22, 2021, at 4:10 p.m. EST. Investors can access a recording of the presentation in the Investors section of the company’s website. This innovative global cannabinoid company is dedicated to advancing cannabis research, technology, and product development across five continents. Cronos is building a disruptive brand portfolio, including well-known brands like PEACE NATURALS and Lord Jones.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.26%
Tags
conferences
-
Rhea-AI Summary

Cronos Group, a global cannabinoid company, announced that Mike Gorenstein, Executive Chairman, will present at the MKM Partners Virtual Conference on December 16, 2020, at 12:30 p.m. EST. The presentation will be accessible via the company's Investors website.

Cronos Group is focused on advancing cannabis research and developing an iconic brand portfolio, including PEACE NATURALS and Spinach.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.97%
Tags
conferences
Rhea-AI Summary

Cronos Group (NASDAQ: CRON) announced on November 25, 2020, that Mike Gorenstein, the Executive Chairman, will speak at the Cowen 2020 Boston Cannabis Conference on December 2, 2020, at 9:20 a.m. EST. This appearance highlights the company's commitment to advancing the cannabis industry. Cronos Group is focused on building a global portfolio of innovative cannabinoid products, including brands like PEACE NATURALS™, COVE™, and Spinach™.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
conferences

FAQ

What is the current stock price of Cronos Group (CRON)?

The current stock price of Cronos Group (CRON) is $3.43 as of September 22, 2026.

What is the market cap of Cronos Group (CRON)?

The market cap of Cronos Group (CRON) is approximately 1.3B.